Ken Griffin’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$41.7M Buy
3,648,133
+407,346
+13% +$6.88M ﹤0.01% 1743
2026
Q2
$71.4M Buy
+3,240,787
New +$71.2M 0.01% 1237

Other funds holding KLRA

Ken Griffin's KLRA Position: Q3 2026 in Review

Ken Griffin increased its Kailera Therapeutics (KLRA) stake by 13% in Q3 2026, buying an estimated $6.88M and bringing the position to 3,648,133 shares worth $41.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Ken Griffin first reported a position in KLRA in Q2 2026 and has held it in 2 quarters since. The position peaked at $71.4M in Q2 2026. 132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Ken Griffin held 3,648,133 shares of Kailera Therapeutics worth $41.7M as of Q3 2026.
  • Ken Griffin bought 407,346 Kailera Therapeutics shares in Q3 2026, an estimated $6.88M.
  • Kailera Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1743 holding.
  • Ken Griffin first reported a position in Kailera Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Ken Griffin's Kailera Therapeutics position peaked at $71.4M in Q2 2026.
  • 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.